What is the warranty period?

The quality guarantee period is 3 years.

Hydrophilic Uretheral Stent Kit

Name: Hydrophilic Uretheral Stent Kit
Brand: Shenzhen Microapproach Medical Technology Co., Ltd.
SKU: 1947588885

Guangdong, ChinaShenzhen Microapproach Medical Technology Co., Ltd.

US$4.00-12.00

500 Pieces

Sample price:US$7.00/piece.Request sample

Product profile

Customization

Available

Type

Surgical Supplies Materials

Material

TPU

Model NO.

US-6-280

Ethylene Oxide Sterilization

Quality Guarantee Period

3 Years

Group

Adult

Logo Printing

Without Logo Printing

Name

Ureteral Stent Single

Usage

Urology Interventional Procedure

Certificate

CE, ISO13485

MOQ

500PCS

Other Name

Double J Stent Catheter

Transport Package

Tyvek Pouch+Inner Box+Outer Box

Specification

4/4.5/5/6/7/8Fr * 22-28cm

Trademark

MicroApproach

Origin

China

Key features

Biocompatible Material: Made of X-ray proof polyurethane, safe for up to 30-day indwelling time.

Hydrophilic Coating: Increases lubricity for easier insertion and placement via endoscopic techniques.

Variable Length Options: Available in 220mm to 280mm lengths to accommodate various ureteral sizes.

Dual Guide Wire Compatible: Compatible with both hydrophilic coating guide wires and zebra guide wires.

CE & ISO13485 Certified: Meets international quality standards with Ethylene Oxide Sterilization.

OEM/ODM Service: Customization available for name and usage, with MOQ of 500 PCS.

Company profile

Shenzhen Microapproach Medical Technology Co., Ltd.

Guangdong, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2015-09-02 CertifiedNearest Port: Shenzhen Port, Hong Kong Port, Guang Zhou PortAverage Response Time: ≤7.58h CertifiedTerms of Payment: LC, T/T, PayPal, etc.

AI-Powered supplier vetting

SummaryMicroApproach Medical is presented as a Shenzhen-based high-tech manufacturer focused on interventional medical products, including guidewires, catheters, introducer sheaths, and related equipment. The available information indicates established R&D activities, including a Japan R&D center, a stated medical-device quality management system, more than 10 production lines, and annual guidewire output of 4,000,000 pieces. Its export activity began in 2015, with exports representing 31%–40% of total sales. The supplier has documented transactions involving guidewires, introducer sheath kits, and Y connector sets with a Vietnam-based buyer, but the evidence does not establish the breadth of its after-sales service, customization process, formal certification portfolio, or overall customer base.

Supplier typeThe supplier is explicitly described as a national high-tech enterprise engaged in the R&D, production, and sales of interventional medical products. Its listed products include guidewires, catheters, introducer sheaths, interventional instruments, and related manufacturing equipment, indicating a specialized medical-device manufacturer rather than a general trading company.

R&D capabilityThe company states that it has strong R&D capability across polymer materials, biomedical engineering, and clinical medicine, maintains an R&D center in Japan, and continuously develops new products based on clinical requirements. These are explicit indicators of an established innovation orientation and technical development capability.

Production capacityThe supplier reports a 5,873.57 m² manufacturing plant, more than 10 production lines, 6–10 quality-control staff, and annual guidewire output of 4,000,000 pieces. It also states that it has established a high-quality production line for medical-device solutions, providing direct evidence of substantial production capability.

Client casesThe available trade records identify a Vietnam destination and one named buyer, CÔNG TY TNHH Y TẾ KHANG KHẢI, with transactions involving introducer sheath kits, a Y connector set, and a guidewire. These records provide evidence of at least one documented customer relationship and product shipments, but do not demonstrate a broad or independently verified customer portfolio.